Alnylam Pharmace. buy melinda
Start price
24.09.13
/
50%
€47.11
Target price
24.03.14
€52.00
Performance (%)
8.26%
End price
24.03.14
€51.00
Summary
This prediction ended on 24.03.14 with a price of €51.00. With a performance of 8.26%, the BUY prediction by melinda for Alnylam Pharmace. closed with a slight gain. melinda has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -1.217% | -1.217% | -25.196% | 18.653% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to melinda what are the pros and cons of Alnylam Pharmace. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Alnylam Pharmace. diskutieren
Übersetzung fehlgeschlagen
Die Übersetzung durch Google Translate ist leider fehlgeschlagen.
(Laufzeit überschritten)
Stopped prediction by melinda for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€180.85
16.10.21
16.10.21
€160.00
16.10.22
16.10.22
-6.22%
24.10.21
24.10.21
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€109.44
27.11.19
27.11.19
-
04.11.21
04.11.21
65.25%
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€81.26
28.09.18
28.09.18
€95.61
22.01.19
22.01.19
-10.01%
22.01.19
22.01.19
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€128.12
12.03.18
12.03.18
€144.32
13.09.18
13.09.18
-33.29%
13.09.18
13.09.18
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€113.81
16.11.17
16.11.17
€126.28
12.03.18
12.03.18
11.75%
12.03.18
12.03.18
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€102.68
20.09.17
20.09.17
€125.38
10.11.17
10.11.17
22.22%
10.11.17
10.11.17
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€113.84
20.09.17
20.09.17
€139.00
10.11.17
10.11.17
22.22%
10.11.17
10.11.17
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€75.00
09.09.17
09.09.17
€85.00
20.09.17
20.09.17
30.03%
20.09.17
20.09.17
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€67.65
09.09.17
09.09.17
€76.67
20.09.17
20.09.17
30.03%
20.09.17
20.09.17
Could be worthwhile Investment >10% per year